The limited scope of medical insurance reimbursement for trametinib tablets
Trametinib is an anti-tumor drug. Trametinib(trametinib) is produced by GlaxoSmithKline, Developed by GSK) Company, it was approved for marketing by the U.S. Food and Drug Administration (FDA) on May 29, 2013, and approved for marketing by the State Food and Drug Administration of China in March 2020. Trametinib will be included in medical insurance in 2023.

Although trametinib is included in medical insurance, the scope of reimbursement is limited. It is used for BRAF V600E mutation-positive unresectable or metastatic melanoma. When used in combination with dabrafenib, it is used for the treatment of patients with BRAF V600E mutation unresectable or metastatic melanoma and for adjuvant treatment of patients with BRAF V600E mutation melanoma. The above indications can be reimbursed, please consult the relevant local departments for details.
The price in domestic pharmacies30 tablets of 2 mg is 9,800 yuan. Patients can be reimbursed, and the cost per box can be reduced a lot. Original drugs are available in Türkiye and are sold in pharmacies30 tablets of 2 mg are 7,900 yuan. The cost of original drugs is relatively high. For patients who cannot be reimbursed, if they consider the economy, they can choose generic drugs that are officially marketed overseas. There is a version of trametinib that is officially marketed in Laos, and it has government approval. Laos Daxiong Pharmaceutical is currently producing this drug, and the retail price of the drug factory is about 3,000 yuan for 2 mg 30 tablets. Patients can choose the drug version according to their own economic situation. The recommended dose of trametinib for adult patients is 2 mg orally once daily. The recommended dose for pediatric patients is based on body weight. Trametinib should be taken at least 1 hour before or 2 hours after a meal until resistance develops. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.
xa0
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)